Guangzhou Improve Med Instrument (300030) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangzhou Improve Med Instrument (300030) has a cash flow conversion efficiency ratio of 0.106x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥70.22 Million ≈ $10.27 Million USD) by net assets (CN¥664.29 Million ≈ $97.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300030 market cap for the company's overall valuation and market capitalisation.
Guangzhou Improve Med Instrument - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Guangzhou Improve Med Instrument's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Guangzhou Improve Med Instrument Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangzhou Improve Med Instrument ranked by their cash flow conversion efficiency. Explore Guangzhou Improve Med Instrument earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Prudential plc
LSE:PRU
|
0.073x |
|
Wholetech System Hitech Ltd
TWO:3402
|
-0.115x |
|
Antibiotice Ia
RO:ATB
|
0.020x |
|
UD Electronic
TWO:3689
|
0.126x |
|
Vinacafe Bien Hoa JSC
VN:VCF
|
-0.043x |
|
Fortress Value Acquisition Corp. V Class A Ordinary Shares
NASDAQ:FVAV
|
0.000x |
|
Seah Steel Corp
KO:003030
|
0.018x |
|
Zhejiang Benli Technology Co. Ltd.
SHE:301065
|
N/A |
Annual Cash Flow Conversion Efficiency for Guangzhou Improve Med Instrument (2006–2025)
The table below shows the annual cash flow conversion efficiency of Guangzhou Improve Med Instrument from 2006 to 2025. View latest Guangzhou Improve Med Instrument stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥655.10 Million ≈ $95.86 Million |
CN¥109.90 Million ≈ $16.08 Million |
0.168x | +31.99% |
| 2024-12-31 | CN¥643.86 Million ≈ $94.22 Million |
CN¥81.84 Million ≈ $11.98 Million |
0.127x | +21.26% |
| 2023-12-31 | CN¥762.33 Million ≈ $111.55 Million |
CN¥79.90 Million ≈ $11.69 Million |
0.105x | +102.49% |
| 2022-12-31 | CN¥820.61 Million ≈ $120.08 Million |
CN¥42.48 Million ≈ $6.22 Million |
0.052x | -68.94% |
| 2021-12-31 | CN¥1.03 Billion ≈ $150.78 Million |
CN¥171.74 Million ≈ $25.13 Million |
0.167x | +18.31% |
| 2020-12-31 | CN¥1.00 Billion ≈ $146.74 Million |
CN¥141.27 Million ≈ $20.67 Million |
0.141x | +140.21% |
| 2019-12-31 | CN¥838.26 Million ≈ $122.66 Million |
CN¥49.16 Million ≈ $7.19 Million |
0.059x | -14.65% |
| 2018-12-31 | CN¥815.47 Million ≈ $119.33 Million |
CN¥56.04 Million ≈ $8.20 Million |
0.069x | -53.43% |
| 2017-12-31 | CN¥963.72 Million ≈ $141.02 Million |
CN¥142.19 Million ≈ $20.81 Million |
0.148x | +507.22% |
| 2016-12-31 | CN¥954.18 Million ≈ $139.63 Million |
CN¥23.19 Million ≈ $3.39 Million |
0.024x | +381.92% |
| 2015-12-31 | CN¥930.46 Million ≈ $136.16 Million |
CN¥-8.02 Million ≈ $-1.17 Million |
-0.009x | +93.77% |
| 2014-12-31 | CN¥782.00 Million ≈ $114.43 Million |
CN¥-108.20 Million ≈ $-15.83 Million |
-0.138x | -340.89% |
| 2013-12-31 | CN¥772.70 Million ≈ $113.07 Million |
CN¥44.38 Million ≈ $6.49 Million |
0.057x | +9.57% |
| 2012-12-31 | CN¥687.93 Million ≈ $100.67 Million |
CN¥36.06 Million ≈ $5.28 Million |
0.052x | -12.56% |
| 2011-12-31 | CN¥648.25 Million ≈ $94.86 Million |
CN¥38.86 Million ≈ $5.69 Million |
0.060x | +23.11% |
| 2010-12-31 | CN¥592.55 Million ≈ $86.71 Million |
CN¥28.86 Million ≈ $4.22 Million |
0.049x | -16.93% |
| 2009-12-31 | CN¥563.53 Million ≈ $82.46 Million |
CN¥33.03 Million ≈ $4.83 Million |
0.059x | -81.36% |
| 2008-12-31 | CN¥78.73 Million ≈ $11.52 Million |
CN¥24.76 Million ≈ $3.62 Million |
0.315x | +591.31% |
| 2007-12-31 | CN¥58.27 Million ≈ $8.53 Million |
CN¥2.65 Million ≈ $387.95K |
0.046x | -86.61% |
| 2006-12-31 | CN¥19.33 Million ≈ $2.83 Million |
CN¥6.57 Million ≈ $961.54K |
0.340x | -- |
About Guangzhou Improve Med Instrument
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising feces and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company… Read more